| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 13.79 | -0.15 (-1.08%) | 10.95 - 14.03 | 0.0 |
Market data as of 6:05PM 05/23/13. Quotes are delayed by at least 15 min.
The investment seeks maximum long-term total return. Under normal circumstances, the fund will invest at least 80% of its net assets in equity securities. It will invest at least 40% of its total assets in securities of non-U.S. issuers. The fund may invest up to 30% of its net assets in securities of issuers in the commercial banking industry.
| Total Return | 7.78% |
|---|---|
| Yield (Trailing 12 Mo.) | 3.05% |
| Expense Ratio | 0.87% |
| Front Load | None |
| Deferred Load | None |
| Minimum Investment | $1,000,000 |
| Management Tenure | 17 Years |
| Fund Inception | 12/19/1995 |
| Timeframe | DELPX | S&P 500 | Foreign Large Value |
|---|---|---|---|
| 1 Month | 5.92% | 1.93% | 4.87% |
| 3 Month | 5.67% | 7.18% | 3.92% |
| Year-to-Date | 9.89% | 12.74% | 8.31% |
| 1 Year | 14.75% | 16.89% | 17.03% |
| 3 Year | 6.38% | 12.80% | 6.02% |
| 5 Year | -1.22% | 5.21% | -1.76% |
| 10 Year | 9.08% | 7.88% | 8.69% |
| Since Inception | 7.78% | 10.38% | -- |
| Basic Materials | 3.74% | |
|---|---|---|
| Consumer Cyclical | 7.07% | |
| Financial Services | 14.20% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 15.93% | |
| Healthcare | 17.41% | |
| Utilities | 9.84% | |
| Communication Services | 11.53% | |
| Energy | 10.07% | |
| Industrials | 4.89% | |
| Technology | 5.32% |
| By Percent | Short | 0% | Long | Net | |
|---|---|---|---|---|---|
| Stock | 0.00 | 0.00 | 0.00 | ||
| Bond | 0.00 | 0.00 | 0.00 | ||
| Other | 0.00 | 0.00 | 0.00 | ||
| Foreign Stock | 0.00 | 99.67 | 99.67 | ||
| Foreign Bond | 0.00 | 0.00 | 0.00 | ||
| Total | 0.00 | 99.67 | 99.67 | ||
| Cash | 0.00 | 0.33 | 0.33 | ||
| Total Net Assets | $533.51M |
|---|---|
| Total Stock Holdings | 48 |
| Total Bond Holdings | 0 |
| Company | YTD Return | % of Assets |
|---|---|---|
| Seven & i Holdings Co., Ltd. | -- | 3.37% |
| Canon, Inc. | -9.16% | 3.33% |
| Sanofi | -- | 3.28% |
| Novartis AG | 17.50% | 3.21% |
| Koninklijke Ahold NV | -- | 3.08% |
| GlaxoSmithKline PLC | 20.09% | 2.91% |
| Takeda Pharmaceutical Co., Ltd. | -- | 2.83% |
| Unilever PLC | 7.86% | 2.82% |
| Zurich Insurance Group AG | 5.86% | 2.80% |
| United Overseas Bank Ltd. | -- | 2.79% |
| Valuation | DELPX | Category Range |
|---|---|---|
| Price/Earnings | 14.74 | |
| Price/Book | 1.42 | |
| Price/Sales | 0.78 | |
| Price/Cash Flow | 6.87 | |
| Dividend Yield | 3.64 | |
| LT Earnings | 8.78 | |
| Historical Earnings | -1.2 | |
| Sales Growth | 1.8 | |
| Cash-Flow Growth | -2.34 | |
| Book-Value Growth | 1.15 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
 |  |  |
| Rating | vs Category | |
|---|---|---|
| Overall |  | |
| Risk | Below Avg | |
| Return | Avg |
| Pretax Return | 6.38% |
|---|---|
| Tax-adjusted Return | 5.27% |
| Tax Cost Ratio | 1.05% |
| Potential Cap Gains | -14.74% |
